≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified haemorrhagic conditions

DOID EFO Endpoint Browser PheWeb

D3_HAEMORRHAGICNAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D69.9
  • Hospital discharge: ICD-9 — 287[8-9]
  • Hospital discharge: ICD-8 — 2879
  • Hospital discharge: excluded ICD-8 — 28790
  • Cause of death: ICD-10 — D69.9
  • Cause of death: ICD-9 — 287[8-9]
  • Cause of death: ICD-8 — 2879
  • Cause of death: excluded ICD-8 — 28790

2 out of 7 registries used, show all original rules.

577

4. Check minimum number of events

None

577

5. Include endpoints

None

577

6. Filter based on genotype QC (FinnGen only)

577

Control definitions (FinnGen only)

Control exclude
D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
D69
Name in latin
Status haemorrhagicus non specificatus

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4553 2524 1979
Only index persons 3723 2126 1597
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.06
Only index persons 0.07 0.08 0.06
Median age at first event (years)
Whole population 55.34 53.94 56.82
Only index persons 52.24 50.26 54.86

-FinnGen-

Key figures

All Female Male
Number of individuals 577 344 233
Unadjusted period prevalence (%) 0.11 0.12 0.10
Median age at first event (years) 53.80 47.74 62.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
522
Matched controls
5221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
8955.6
323.0
442
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
263.8
88.4
88
*
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
55.2
52
*
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
50.9
48
*
D69.0
ICD-10 Finland
Allergic purpura
+∞
39.0
37
*
D68.0
ICD-10 Finland
Von Willebrand disease
+∞
32.6
31
*
D68.9
ICD-10 Finland
Coagulation defect, unspecified
+∞
22.0
21
*
B02AA02
ATC
tranexamic acid; systemic
3.2
19.5
116
428
R50.9
ICD-10 Finland
Fever, unspecified
3.2
18.8
111
405
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
18.6
88
272
H02AB06
ATC
prednisolone; systemic
2.2
17.3
267
1660
R4110
NOMESCO Finland
Physiotherapy
2.5
16.7
167
835
H02AB07
ATC
prednisone; oral
3.0
16.3
106
412
D68.8
ICD-10 Finland
Other specified coagulation defects
62.0
15.9
18
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
15.7
245
1510
C03CA01
ATC
furosemide; systemic
2.3
15.2
178
957
ZXD05
NOMESCO Finland
Urgent procedure
2.3
15.1
191
1065
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
14.9
173
925
WW500
NOMESCO Finland
Blood transfusion
5.8
14.9
42
77
ZX120
NOMESCO Finland
Intravenous
3.3
14.8
78
261
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
14.6
134
634
N02AX02
ATC
tramadol; systemic, rectal
2.1
14.6
237
1473
XW000
NOMESCO Finland
Bone marrow biopsy
5.2
13.9
43
88
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
13.8
72
239
ZXE00
NOMESCO Finland
One hour or less
2.1
13.7
231
1444
2879X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Unspecified haemorrhagic conditions
+∞
13.6
13
*
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
143.6
13.5
14
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.2
13.2
73
251
A02BC02
ATC
pantoprazole; systemic
2.0
13.1
346
2570
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
13.1
73
254
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
12.5
12
*
D69.1
ICD-10 Finland
Qualitative platelet defects
+∞
12.5
12
*
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
27.4
12.1
16
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
12.0
90
378
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.0
12.0
48
128
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
12.0
181
1068
L04AA06
ATC
mycophenolic acid; systemic
12.1
11.9
21
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
11.9
47
124
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
11.7
106
494
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
11.5
11
*
28798
ICD-8 Finland
Purpura and other haemorrhagic conditions, Purpura et status haemorrhagicus alius
+∞
11.5
11
*
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
122.6
11.5
12
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.6
11.4
90
390
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.3
91
396
M05BA04
ATC
alendronic acid; oral
3.2
11.3
60
202
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
11.1
142
777
R04.0
ICD-10 Finland
Epistaxis
3.5
11.0
52
160
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
11.0
94
423
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
10.9
128
676
Z3226
NOMESCO Finland
Physiotherapist
2.3
10.8
116
588
L04AX01
ATC
azathioprine; systemic
4.3
10.7
39
96
TK800
NOMESCO Finland
Hemodialysis
10.3
10.6
20
20
Z3231
NOMESCO Finland
Registered nurse
2.0
10.5
164
970
126
Kela drug reimbursment
Chronic coagulation defects
+∞
10.4
10
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.4
10.1
36
87
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
10.0
202
1311
B01AA03
ATC
warfarin; systemic
2.2
9.8
113
587
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
9.6
210
1393
C07AB07
ATC
bisoprolol; oral
1.8
9.6
234
1614
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.8
9.5
21
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
9.4
194
1263
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
9.4
9
*
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
9.4
9
*
M04AA01
ATC
allopurinol; systemic
2.5
9.2
74
323
J01FF01
ATC
clindamycin; systemic
2.0
9.1
145
857
D07AB08
ATC
desonide; topical
2.6
9.1
70
297
Z2221
NOMESCO Finland
Medical doctor
1.9
9.1
160
983
P01AB01
ATC
metronidazole; oral, rectal
1.8
9.0
203
1355
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
9.0
46
152
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
9.0
145
861
A46
ICD-10 Finland
Erysipelas
2.4
9.0
82
382
K92.1
ICD-10 Finland
Melaena
3.5
8.5
39
118
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
8.4
96
496
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
+∞
8.4
8
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
11.0
8.3
15
14
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
8.2
92
469
B01AB05
ATC
enoxaparin; parenteral
1.9
8.1
151
938
J01MA12
ATC
levofloxacin; systemic
2.0
8.1
107
586
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.2
8.0
41
136
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
7.9
54
215
R06.0
ICD-10 Finland
Dyspnoea
1.9
7.8
132
793
UJF32
NOMESCO Finland
Coloscopy
1.9
7.7
133
804
C03DA01
ATC
spironolactone; oral
2.4
7.6
64
285
B03BA03
ATC
hydroxocobalamin; parenteral
3.1
7.4
39
132
2878X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Other specified haemorrhagic conditions
+∞
7.3
7
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.8
7.2
411
3522
6BA02
NOMESCO Finland
NA
30.5
7.2
9
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.8
7.1
19
34
Z49.1
ICD-10 Finland
Extracorporeal dialysis
12.2
7.1
12
10
127
Kela drug reimbursment
Transplant complication
9.0
7.1
14
16
J01DA01
ATC
[U] cefalexin; systemic
1.6
7.0
321
2572
H02AB04
ATC
methylprednisolone; systemic
2.1
6.9
78
400
I34.1
ICD-10 Finland
Mitral (valve) prolapse
4.5
6.9
23
53
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
6.9
29
83
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
6.8
43
162
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
40.6
6.8
8
*
J05AB11
ATC
valaciclovir; oral
2.2
6.7
72
360
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
6.7
105
611
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
6.6
58
265
N18.8
ICD-10 Finland
Other chronic renal failure
4.5
6.6
22
51
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
6.6
258
1968
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
6.6
50
213
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.9
6.6
13
15
S20.2
ICD-10 Finland
Contusion of thorax
3.3
6.5
31
98
C08CA01
ATC
amlodipine; oral
1.7
6.5
164
1110
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
70.7
6.4
7
*
A02BC01
ATC
omeprazole; systemic
1.7
6.4
137
884
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.1
6.4
23
58
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
6.3
47
195
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.4
6.3
29
90
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
6.3
50
217
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
6.3
44
179
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
+∞
6.3
6
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
27.0
6.2
8
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
27.0
6.2
8
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
27.0
6.2
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.2
108
648
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
6.2
60
288
A02BC03
ATC
lansoprazole; oral
1.7
6.2
139
908
R03AC02
ATC
salbutamol; inhalant
1.6
6.2
256
1973
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
6.1
165
1135
A11CC03
ATC
alfacalcidol; systemic
5.0
6.1
18
37
L04AD01
ATC
ciclosporin; systemic
5.0
6.1
18
37
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
10.2
6.1
11
11
L04AA01
ATC
[U] ciclosporin; systemic
6.1
6.0
15
25
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
4.7
6.0
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
37
19
20.74
47.97
1.5
3.4
%
106.3
92.6
0.95
37
19
(3018677) aPTT in Platelet poor plasma by Coagulation assay
183
655
3.63
42.07
3.6
2.0
s
31.2
29.6
2.29
178
639
(3036489) Thrombin time
77
152
5.69
38.12
2.8
2.2
s
20.5
21.5
1.04
72
140
(3012095) Magnesium [Moles/volume] in Serum or Plasma
162
675
2.95
27.52
4.1
3.1
mmol/l
0.8
0.8
1.20
154
638
(3022948) Iron [Moles/volume] in Serum or Plasma
159
683
2.83
25.29
3.3
2.4
umol/l
11.3
12.9
2.21
151
629
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
143
586
2.91
24.78
3.4
2.5
%
20.5
21.9
0.61
134
506
(3042111) Morphology [Interpretation] in Bone marrow Narrative
40
63
6.75
24.67
1.7
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
333
2065
2.45
24.20
10.7
5.4
%
0.6
0.7
0.43
318
1923
(42870588) Differential panel, method unspecified - Blood
266
1495
2.45
24.06
9.3
5.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
125
483
3.03
24.02
4.0
2.5
%
1.8
1.7
0.59
117
439
(3001604) Monocytes [#/volume] in Blood
351
2241
2.45
23.72
10.7
5.3
e9/l
0.6
0.6
1.90
312
1934
(3006315) Basophils [#/volume] in Blood
352
2255
2.44
23.53
10.7
5.3
e9/l
0.0
0.0
0.09
313
1948
(3019198) Lymphocytes [#/volume] in Blood
358
2314
2.44
23.41
10.9
5.3
e9/l
1.8
1.9
1.02
320
2040
(3006504) Eosinophils/100 leukocytes in Blood
338
2131
2.42
23.37
10.7
5.3
%
2.6
2.9
1.23
324
1980
(3019069) Monocytes/100 leukocytes in Blood
339
2141
2.41
23.33
10.9
5.6
%
9.0
8.6
1.82
326
2005
(3004789) Transferrin [Mass/volume] in Serum or Plasma
146
626
2.78
23.09
3.3
2.4
g/l
2.3
2.3
0.60
141
585
(3002030) Lymphocytes/100 leukocytes in Blood
345
2203
2.41
23.05
10.8
5.5
%
26.5
27.9
1.44
328
2053
(3013115) Eosinophils [#/volume] in Blood
357
2339
2.38
22.12
11.0
5.7
e9/l
0.2
0.2
0.85
321
2061
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
53
123
4.64
21.55
3.8
3.0
u/ml
0.3
0.3
0.54
33
67
(3005719) IgG [Mass/volume] in Serum or Plasma
93
322
3.25
21.41
4.6
2.6
g/l
10.8
10.4
0.40
85
292
(3013650) Neutrophils [#/volume] in Blood by Automated count
384
2621
2.39
21.30
15.2
8.5
e9/l
4.1
4.1
0.15
344
2289
(3018010) Neutrophils/100 leukocytes in Blood
334
2175
2.27
20.32
10.6
5.3
%
58.7
57.4
1.24
320
2038
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
271
1630
2.25
19.90
4.9
3.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
64
182
3.83
19.87
1.8
1.8
g/l
1.5
1.5
0.16
51
164
(3023520) Reticulocytes [#/volume] in Blood
92
342
3.01
18.66
3.1
2.2
e9/l
74.6
68.0
0.98
66
277
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
344
2325
2.19
18.34
8.6
5.6
umol/l
11.7
11.2
0.28
328
2197
(3028026) IgM [Mass/volume] in Serum or Plasma
78
266
3.23
18.31
2.3
1.5
g/l
1.2
1.4
0.33
70
244
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
25
9.11
17.76
2.3
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
219
1253
2.21
17.71
4.1
3.0
e6/l
0.5
0.4
0.42
175
926
(3020630) Protein [Mass/volume] in Serum or Plasma
91
350
2.90
17.31
3.9
2.5
g/l
65.9
66.8
0.47
84
318
(3037522) Nuclear Ab [Titer] in Serum
131
607
2.50
17.24
1.6
1.3
titre
870.0
458.7
0.92
32
135
(3026782) Osmolality of Urine
173
907
2.30
17.23
3.8
2.7
mosm/kgh2o
507.4
558.5
2.22
154
769
(3002582) Erythrocytes [#/volume] in Urine
234
1386
2.16
17.23
4.3
3.2
e6/l
73.6
108.4
0.26
190
1053
(36304419) Bacteria [Presence] in Urine
213
1224
2.17
16.88
4.0
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
97
4.47
16.24
2.0
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
261
1640
2.08
16.20
5.3
3.6
e6/l
114.0
108.2
0.05
203
1145
(3021589) Normoblasts [#/volume] in Blood
306
2047
2.05
15.91
15.8
8.7
e9/l
0.0
0.0
0.14
252
1663
(3001122) Ferritin [Mass/volume] in Serum or Plasma
307
2061
2.05
15.75
4.1
2.7
ug/l
174.2
106.1
2.72
292
1917
(3015171) Extractable nuclear Ab [Units/volume] in Serum
56
170
3.54
15.75
1.3
1.2
u/ml
0.3
2.5
—
6
11
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
197
1139
2.11
15.04
3.3
2.2
mg/l
4.0
3.1
2.95
174
987
(3024561) Albumin [Mass/volume] in Serum or Plasma
288
1911
2.01
15.04
7.6
4.3
g/l
35.1
35.7
1.07
269
1782
(3023368) Bacteria identified in Blood by Culture
204
1196
2.09
15.00
6.1
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
198
1151
2.10
14.87
8.8
6.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
170
948
2.12
14.13
3.3
2.7
e6/l
6.4
6.1
0.08
157
832
(3004588) Protein electrophoresis panel - Serum or Plasma
76
295
2.82
14.12
3.8
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
230
1450
1.97
13.52
3.3
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
138
720
2.20
13.52
3.5
2.7
e6/l
3.4
2.4
0.45
75
383
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
143
758
2.18
13.46
3.1
2.6
e6/l
1.3
1.0
0.43
80
419
(3003458) Phosphate [Moles/volume] in Serum or Plasma
115
557
2.33
13.46
9.0
5.4
mmol/l
1.1
1.0
1.21
110
512
(3045142) Bone marrow Pathology biopsy report
23
39
6.10
13.15
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
81
337
2.63
13.13
5.8
4.1
%
0.3
0.1
0.79
33
98
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
314
2212
1.92
13.13
11.2
6.0
mmol/l
1.2
1.2
0.98
274
1862
(3032080) INR in Blood by Coagulation assay
266
1786
1.91
12.77
15.6
8.2
inr
1.3
1.2
0.74
89
518
(3026493) Urate [Moles/volume] in Serum or Plasma
189
1132
2.00
12.73
3.6
2.6
umol/l
7867.5
8545.9
0.05
169
982
(3002179) Metamyelocytes/100 leukocytes in Blood
76
312
2.65
12.64
6.0
4.1
%
0.8
0.5
0.44
28
71
(3017181) Myelocytes/100 leukocytes in Blood
83
358
2.54
12.48
5.7
4.0
%
1.2
1.0
0.34
34
112
(3018418) pH of Serum or Plasma
211
1324
1.94
12.33
6.7
3.7
ph
7.4
7.4
0.47
45
247
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
101
481
2.33
12.22
2.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
75
312
2.61
12.14
5.9
4.2
%
0.0
0.1
0.39
28
79
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
287
2000
1.87
12.05
9.6
5.5
mmol/l
1.2
1.2
0.68
271
1808
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
152
3.28
11.96
2.6
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
435
3477
2.02
11.84
12.6
6.8
u/l
82.0
78.9
0.68
422
3253
(3002032) Base excess in Venous blood by calculation
89
408
2.40
11.72
5.7
4.0
mmol/l
1.8
2.0
0.14
73
325
(40760888) Immunoglobulin light chains.free panel - Serum
34
90
3.95
11.63
2.9
4.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
21
37
5.85
11.55
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
27
6.85
11.52
2.3
2.4
%
11.8
13.1
—
8
17
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
172
1029
1.96
11.43
2.5
1.7
mg/l
1.2
1.1
0.06
140
783
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
72
304
2.56
11.29
2.2
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
38
5.70
11.24
3.5
2.1
e9/l
0.9
1.1
0.27
15
19
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
102
507
2.23
11.10
4.0
2.5
umol/l
6.3
7.7
0.45
86
440
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
126
688
2.06
10.76
2.1
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
198
1269
1.85
10.51
3.5
3.0
ng/l
2328.8
1311.7
1.35
169
1070
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
91
441
2.26
10.50
3.9
3.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
15
8.84
10.26
2.7
2.7
u/ml
738.2
544.0
0.60
13
15
(3034860) Kappa light chains.free [Mass/volume] in Serum
40
129
3.26
10.23
4.3
3.4
mg/l
42.5
105.5
0.71
31
107
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
40
129
3.26
10.23
4.3
3.5
mg/l
37.4
32.5
0.34
31
107
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
95
477
2.19
10.04
2.0
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
85
408
2.27
10.02
3.0
2.3
u/l
30.0
32.0
0.38
73
339
(3012544) pH of Venous blood
87
424
2.24
9.88
5.5
4.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
46
165
2.94
9.84
1.8
1.8
ug/l
0.5
2.6
0.67
41
148
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
22
6.97
9.77
1.8
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
22
6.97
9.77
1.8
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
39
128
3.20
9.70
4.4
3.4
ratio
1.1
2.3
—
7
15
(3009261) Glucose [Presence] in Urine by Test strip
307
2279
1.74
9.65
5.2
3.7
estimate
0.0
0.0
0.50
64
410
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
208
1388
1.78
9.47
3.5
2.4
u/l
55.6
57.5
0.43
196
1293
(3007853) Bacteria identified in Skin by Aerobe culture
100
524
2.10
9.45
2.1
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
125
3.18
9.42
1.3
1.2
u/ml
64.1
2.6
—
5
16
(3035350) Ketones [Presence] in Urine by Test strip
302
2243
1.73
9.38
5.1
3.6
estimate
0.0
0.0
0.00
68
427
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
71
3.94
9.33
2.0
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
71
3.94
9.33
11.1
3.7
iu/ml
256.3
184.4
—
8
5
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
100
3.44
9.31
1.8
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
302
2249
1.72
9.24
6.9
5.0
estimate
0.0
0.0
0.50
67
423
(3042936) Bacteria identified in Isolate by Culture
113
625
2.00
9.21
2.8
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
152
929
1.86
9.20
1.9
1.4
g/l
2.7
2.4
1.15
96
568
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
38
127
3.13
9.18
1.3
1.2
u/ml
8.2
6.3
—
8
23
(4062490)
21
46
4.70
9.13
1.6
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
68
3.96
9.05
1.4
1.2
u/ml
3.0
4.4
—
8
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
55
4.31
8.99
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
73
345
2.28
8.90
11.8
8.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
93
3.47
8.88
1.7
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
39
135
3.03
8.88
1.4
1.2
u/ml
59.4
1.2
—
5
8
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
170
1101
1.77
8.40
3.4
2.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
202
1374
1.72
8.40
4.2
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
103
3.23
8.23
1.9
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
46
4.47
8.21
2.4
1.5
pg
32.8
32.4
0.14
20
46
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
58
259
2.38
8.05
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
95
517
2.00
8.05
2.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
212
1475
1.69
8.04
4.3
2.8
u/l
28.8
30.8
0.70
202
1405
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
65
3.81
7.98
1.5
1.2
u/ml
1.5
4.7
—
6
23
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
80
410
2.10
7.97
3.1
2.3
g/l
0.2
0.2
0.15
74
380
(3021879) Hepatitis B virus core Ab [Presence] in Serum
66
315
2.24
7.85
1.8
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
44
4.43
7.73
1.4
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
36
4.84
7.68
1.8
2.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
1025
1.73
7.42
4.5
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
334
2643
1.63
7.42
7.8
4.5
mmol/l
6.6
6.7
0.19
318
2445
(3031040) Bacteria [#/volume] in Urine by Automated count
373
3034
1.65
7.41
6.2
4.4
e6/l
735.9
2947.2
—
9
55
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
34
121
2.92
7.40
1.4
1.2
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
7
0
+∞
7.30
1.6
0.0
s
40.5
—
—
7
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
283
2158
1.61
7.27
6.0
3.9
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
28
91
3.18
7.10
4.5
2.7
umol/l
31.3
34.5
0.33
23
73
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
23
5.76
7.09
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
247
1842
1.60
6.84
3.0
2.3
nmol/l
73.4
77.0
1.19
233
1639
(3037467) Urinalysis macro (dipstick) panel - Urine
385
3188
1.62
6.83
6.6
4.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
6
16.93
6.76
1.6
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
30
105
2.96
6.73
1.4
1.2
u/ml
47.3
27.1
—
8
12
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
234
1729
1.59
6.70
4.9
3.7
ng/l
34.8
37.4
0.15
157
1180
(3000093) Morphology [Interpretation] in Blood Narrative
16
37
4.42
6.53
1.6
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
238
1774
1.58
6.52
2.4
2.0
pmol/l
94.7
95.1
0.05
155
901
(3015377) Calcium [Moles/volume] in Serum or Plasma
209
1513
1.60
6.47
4.4
3.2
mmol/l
2.3
2.4
0.16
189
1328
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
42
4.14
6.39
2.7
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
81
3.18
6.39
1.6
1.3
u/ml
215.6
233.4
0.12
14
45
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
81
3.18
6.39
1.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
157
1062
1.66
6.39
1.8
1.5
nmol/l
20.4
20.8
0.08
134
905
(3048689) Calprotectin [Mass/mass] in Stool
96
565
1.84
6.38
2.7
2.3
ug/g
152.5
117.8
0.36
75
440
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
82
3.14
6.26
1.6
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
100
600
1.81
6.24
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
51
242
2.21
6.16
1.8
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
128
2.67
6.15
3.4
3.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
105
2.86
6.14
2.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
39
4.19
6.12
1.6
2.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
8
12.69
6.10
1.6
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
17
45
3.86
5.85
1.8
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
120
2.67
5.81
1.7
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
157
2.45
5.77
5.0
2.1
g/l
3.4
3.2
0.49
30
123
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
16
41
3.99
5.75
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
16
41
3.99
5.75
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
16
41
3.99
5.75
1.3
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
61
3.36
5.63
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
16
42
3.89
5.57
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
52
260
2.10
5.53
1.6
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
24
83
2.97
5.52
3.8
4.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
41
186
2.30
5.52
2.9
2.1
u/l
44.5
40.0
0.60
35
167
(40760892) CBC W Ordered Manual Differential panel - Blood
148
1019
1.61
5.52
9.0
4.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
40
180
2.31
5.49
2.2
2.3
u/l
6184.1
3381.5
0.33
16
72
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
168
2.35
5.43
4.9
2.0
g/l
7.6
7.4
0.26
30
125
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
168
2.35
5.43
4.9
2.0
g/l
3.7
3.8
0.17
30
121
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
168
2.35
5.43
4.9
2.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
21
68
3.17
5.39
3.2
3.6
%
59.8
64.5
0.38
21
68
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
48
3.62
5.36
2.8
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
66
364
1.92
5.35
3.1
2.6
ml/min/173m2
69.3
67.4
0.15
43
155
(40768795) Lymph node Pathology biopsy report
15
39
3.92
5.29
1.2
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
92
570
1.73
5.11
37.6
23.2
inr
1.8
1.3
—
10
83
(3002256) Pathology report gross observation
92
571
1.73
5.08
1.4
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
154
2.35
5.06
1.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
110
718
1.66
5.04
2.1
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
122
820
1.62
4.97
1.9
1.7
nmol/l
1094.0
1167.4
0.39
95
624
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
182
1344
1.52
4.91
2.8
2.0
u/l
259.2
315.3
0.19
177
1268
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
57
3.23
4.80
1.0
1.0
—
—
—
0
0
(4035726)
65
372
1.84
4.71
1.5
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
394
3413
1.49
4.62
6.6
3.9
mm/h
15.2
11.7
3.53
375
3148
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
59
3.12
4.55
1.2
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
39
3.65
4.51
2.3
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
76
2.83
4.49
1.2
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
82
2.75
4.46
2.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
30
4.06
4.45
1.4
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
77
2.79
4.39
1.9
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
83
2.72
4.37
2.4
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
365
3134
1.45
4.34
4.2
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
80
501
1.69
4.27
1.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
224
1766
1.44
4.21
5.7
3.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
41
3.47
4.21
1.6
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
432
3850
1.49
4.08
32.0
16.3
%
14.1
13.7
5.46
425
3787
(3051611) Lipemic interference index of Serum or Plasma
13
37
3.57
4.07
4.0
3.7
—
—
—
0
0
(3024471) HLA-A [Type]
7
7
10.10
4.02
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
164
1228
1.47
4.02
6.0
4.0
estimate
0.0
0.0
0.50
63
414
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
28
3.99
3.99
1.3
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
28
3.99
3.99
4.1
3.7
—
—
—
0
0
(44790049)
15
48
3.18
3.95
1.3
1.4
—
—
—
0
0
(44790047)
15
48
3.18
3.95
1.3
1.4
—
—
—
0
0
(44790048)
15
48
3.18
3.95
1.3
1.4
—
—
—
0
0
(44806118)
15
48
3.18
3.95
1.3
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
111
769
1.55
3.93
1.3
1.3
iu/ml
24.6
33.3
0.61
37
247
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
38
3.48
3.92
1.0
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
19
71
2.73
3.86
1.4
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
77
2.65
3.84
2.4
1.4
u/ml
107.4
113.1
—
5
13
(3003396) Base excess in Arterial blood by calculation
76
484
1.66
3.81
10.4
6.9
mmol/l
1.5
1.2
0.28
56
388
(3009542) Hematocrit [Volume Fraction] of Blood
462
4202
1.50
3.68
25.6
14.4
%
38.4
39.7
2.32
336
3091
(3012441) Differential panel - Pleural fluid
13
40
3.30
3.64
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
120
860
1.50
3.62
4.3
3.6
ng/l
1618.2
342.8
0.54
95
643
(3019550) Sodium [Moles/volume] in Serum or Plasma
502
4656
1.60
3.58
29.0
15.4
mmol/l
139.3
139.7
2.34
490
4519
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
124
898
1.49
3.55
1.7
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
138
2.16
3.55
3.7
2.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
45
252
1.85
3.53
4.3
3.0
e6/l
0.3
0.2
0.65
45
244
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
118
849
1.49
3.49
3.6
2.9
mmol/l
2.5
2.4
0.15
102
744
(3018405) Lactate [Moles/volume] in Arterial blood
33
167
2.04
3.46
4.2
3.6
mmol/l
1.1
1.3
1.09
33
160
(4268621)
14
47
3.03
3.43
2.4
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
47
3.03
3.43
3.3
2.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
277
1.80
3.43
1.3
1.2
u/ml
305.1
223.6
0.15
41
250
(3023103) Potassium [Moles/volume] in Serum or Plasma
502
4667
1.58
3.41
29.8
15.5
mmol/l
4.0
4.0
0.47
489
4523
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
233
1.87
3.40
2.0
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
53
2.88
3.38
1.2
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
10
7.07
3.37
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
59
366
1.68
3.28
5.4
3.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
15
54
2.83
3.27
1.3
1.1
g/l
1.4
1.4
0.04
15
48
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
45
259
1.80
3.25
4.0
3.4
pmol/l
4.5
4.5
0.15
37
231
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
347
3037
1.36
3.17
4.3
3.0
u/l
52.5
45.4
1.21
324
2844
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
494
4595
1.52
3.14
28.1
13.4
mg/l
23.4
22.9
0.13
439
3638
(46235355) HIV 1 and 2 tests - Meaningful Use set
120
884
1.45
3.14
2.3
1.9
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
20
86
2.37
3.11
2.1
2.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
39
3.12
3.10
1.2
1.5
%
76.0
64.5
—
5
31
(3011648) Oxygen content in Venous blood
10
29
3.49
3.06
4.1
6.1
%
10.2
12.0
—
10
29
(40768806) Pleura Pathology biopsy report
13
45
2.93
3.04
1.3
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
60
382
1.64
3.04
6.1
3.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
12
5.89
3.03
1.6
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
61
391
1.63
3.01
12.1
7.6
g/l
113.5
121.1
2.07
61
382
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
21
4.34
3.00
1.8
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
21
4.34
3.00
1.8
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
88
2.32
2.97
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
88
2.32
2.97
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
17
4.76
2.92
1.8
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
17
4.76
2.92
1.8
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
70
2.47
2.90
1.5
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
9
6.72
2.87
1.8
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
165
1.93
2.86
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
65
2.50
2.81
1.3
1.5
—
—
—
0
0
(4211845)
8
18
4.49
2.80
2.4
3.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
18
4.49
2.80
1.9
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
162
1281
1.37
2.80
5.1
3.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
31
3.27
2.78
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
6
8.39
2.75
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
31
168
1.89
2.73
6.2
4.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
60
2.54
2.72
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
45
277
1.68
2.61
5.0
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
461
4273
1.39
2.60
22.9
12.3
ml/min/173m2
81.3
81.7
0.10
413
3475
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
121
2.03
2.59
1.8
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
20
4.04
2.57
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
7
7.19
2.55
1.6
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
7
7.19
2.55
1.6
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
11
5.50
2.55
2.2
2.5
ug/l
51.2
95.9
—
6
11
(3026389) Candida sp identified in Specimen by Organism specific culture
14
56
2.54
2.55
1.1
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
10
33
3.07
2.53
1.1
1.4
—
—
—
0
0
(4010399)
49
312
1.62
2.51
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
67
460
1.52
2.49
3.4
4.2
ug/l
29.5
23.2
0.12
56
387
(3006462) Nitrate [Presence] in Urine
7
16
4.41
2.48
2.6
3.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
45
2.70
2.46
1.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
13
51
2.58
2.46
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
51
2.58
2.46
3.7
3.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
182
1.80
2.45
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
24
124
1.98
2.44
3.7
2.9
kpa
8.0
8.4
0.54
24
109
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
283
1.64
2.42
4.5
3.5
mmol/l
1.4
1.9
0.34
32
203
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
34
2.98
2.42
1.7
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
121
934
1.37
2.41
1.8
1.7
pmol/l
431.2
6258262.6
0.50
94
799
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
8
6.29
2.37
1.4
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
135
1063
1.35
2.37
1.3
1.3
u/ml
1.8
1.7
0.03
32
293
(3000494) Fungus identified in Specimen by Culture
75
533
1.47
2.36
1.7
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
78
2.22
2.33
1.9
2.4
%
14.8
16.0
—
7
40
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
35
2.89
2.31
1.4
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
2.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
2.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
2.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
47
2.59
2.28
4.3
3.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
218
1847
1.29
2.26
2.4
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
18
3.92
2.26
3.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
18
3.92
2.26
3.4
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
62
0.00
2.23
0.0
1.4
—
7.7
—
0
40
(3044242) Glucose [Moles/volume] in Arterial blood
9
29
3.14
2.23
1.7
4.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
76
550
1.44
2.19
1.7
1.7
%
1.5
1.4
0.65
65
486
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
19
3.72
2.15
3.4
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
30
3.03
2.15
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
36
221
1.67
2.14
5.0
3.5
—
—
—
0
0
(3009343) pH of Capillary blood
46
301
1.57
2.13
4.5
3.5
ph
7.4
7.4
—
5
28
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
37
2.73
2.11
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
43
2.59
2.10
1.3
1.0
u/ml
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
31
2.93
2.08
2.4
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
10
5.03
2.07
1.4
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
20
3.53
2.06
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
15
4.03
2.04
3.8
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
118
1.90
2.04
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
97
1.99
2.02
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
164
1.74
1.98
2.4
2.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
21
3.36
1.97
9.9
3.2
u/l
225.4
210.7
—
7
21
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
59
416
1.47
1.96
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
11
4.57
1.94
1.2
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
11
4.57
1.94
4.0
5.5
mmol/l
24.3
24.8
—
5
11
(3017569) Oxygen content in Arterial blood
8
27
2.99
1.94
1.8
4.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
22
3.21
1.88
1.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
328
2964
1.25
1.87
3.4
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
59
2.23
1.85
3.9
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
59
2.23
1.85
3.9
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
59
2.23
1.85
3.9
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
12
4.19
1.82
1.4
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
12
4.19
1.82
1.4
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
12
4.19
1.82
1.4
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
12
4.19
1.82
1.4
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
12
4.19
1.82
4.4
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
160
1335
1.27
1.82
3.7
3.1
mmol/l
7.2
7.4
0.22
136
1110
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
131
1.79
1.80
2.0
1.6
iu/ml
0.1
0.1
—
8
27
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
29
2.78
1.79
2.0
3.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
60
2.19
1.79
3.9
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
60
2.19
1.79
3.9
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
60
2.19
1.79
3.9
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
47
2.37
1.78
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
95
743
1.33
1.74
1.3
1.3
u/ml
4.4
9.6
1.08
32
296
(3020682) Albumin/Creatinine [Ratio] in Urine
155
1296
1.27
1.73
4.9
4.0
mg/mmol
22.5
8.8
1.17
116
806
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
13
3.87
1.72
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
19
104
1.86
1.69
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
302
1.49
1.69
2.3
2.8
e9/l
4.2
4.0
0.32
38
244
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
19
3.18
1.66
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
3.4
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
3.4
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
3.4
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
3.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
128
1.75
1.62
5.9
4.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
136
1.72
1.61
1.8
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
99
1.84
1.59
1.5
1.6
e6/l
8666.7
21434.0
0.98
12
71
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.3
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
20
3.02
1.58
1.2
1.2
iu/ml
634.3
118.1
—
6
20
(3012516) Albumin [Mass/volume] in Urine
146
1225
1.26
1.57
3.9
3.2
mg/l
875.4
271.0
0.56
105
782
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
122
1.75
1.56
1.1
1.4
u/l
14.9
10.5
0.66
16
95
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
379
3516
1.23
1.54
4.9
3.9
pmol/l
14.7
14.7
0.11
355
3199
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
123
1.73
1.53
1.4
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
15
3.35
1.52
1.2
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
25
154
1.65
1.52
3.2
3.5
g/l
0.2
0.3
0.22
13
56
(3017704) Immunofixation for Urine
6
21
2.88
1.51
1.0
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
21
2.88
1.51
1.3
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
21
2.88
1.51
1.3
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
16
3.14
1.44
6.8
3.5
%
55.8
52.4
—
5
16
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
22
2.74
1.43
1.3
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
149
1.64
1.43
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
43
305
1.44
1.43
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
45
323
1.43
1.41
2.0
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
150
1.63
1.40
1.1
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
74
1.91
1.40
1.4
1.1
—
16.1
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
53
2.10
1.39
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
41
2.21
1.37
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
224
1.50
1.37
5.2
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
122
1019
1.25
1.36
5.4
4.0
kg/l
1.0
1.0
0.68
16
149
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
17
2.96
1.36
2.4
1.2
ug/l
11.8
8.5
—
5
17
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
17
2.96
1.36
2.0
1.8
mg/l
53.0
114.1
—
5
12
(36660697) Celiac disease serology panel - Serum
50
369
1.39
1.35
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
152
1.60
1.34
1.1
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
54
2.06
1.33
1.2
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
504
4854
1.30
1.32
17.6
9.6
u/l
25.3
25.3
0.01
496
4684
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
177
1.55
1.31
2.1
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
76
1.86
1.31
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
24
2.52
1.30
1.2
1.9
u/field
1.0
1.6
—
6
19
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
202
1.51
1.30
17.0
9.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
62
1.96
1.28
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
10
48
2.10
1.28
2.8
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
25
2.41
1.24
1.2
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
25
2.41
1.24
2.3
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
45
2.02
1.23
5.0
2.6
u/ml
24.3
53.4
—
9
45
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
49
2.06
1.22
1.4
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
444
4228
1.22
1.20
5.7
4.6
mu/l
1.9
2.2
0.43
418
3866
(3013512) EKG study
152
1317
1.21
1.20
4.4
3.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
86
1.76
1.20
4.5
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
72
1.82
1.16
1.4
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
20
2.51
1.15
2.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
8
40
2.01
1.12
2.3
2.2
ml
1161.3
560.4
—
8
24
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
105
1.64
1.07
3.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
75
1.75
1.03
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
257
1.39
1.01
2.0
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
496
4800
1.24
1.00
24.8
12.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
23
2.18
0.98
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
36
1.96
0.97
2.4
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
31
0.00
0.96
0.0
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
17
109
1.58
0.94
1.7
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
37
1.90
0.94
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
37
1.90
0.94
2.4
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
433
4147
1.18
0.94
6.5
5.6
mmol/mol
39.9
39.8
0.16
397
3870
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
28
2.15
0.91
1.5
1.7
g/l
1.0
1.0
—
6
28
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
130
1141
1.18
0.89
1.5
1.6
mmol/l
1.5
1.4
1.44
109
967
(3000570) Elastase.pancreatic [Mass/mass] in Stool
18
119
1.53
0.89
1.7
1.4
ug/g
303.2
313.0
—
6
71
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
119
1.53
0.89
1.9
1.7
iu/l
3.8
6.5
—
7
40
(4306422)
10
56
1.80
0.88
1.5
1.2
—
—
—
0
0
(4281824)
8
46
1.75
0.82
1.6
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
155
1.44
0.82
2.2
1.6
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
24
0.00
0.79
0.0
1.0
—
33.6
—
0
15
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
247.1
—
0
15
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
516.4
—
0
16
(40768441) Liver Pathology biopsy report
6
33
1.83
0.79
1.7
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
332
1.29
0.78
1.2
1.2
iu/ml
131.9
163.9
0.25
16
134
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
454
4386
1.16
0.78
5.0
4.4
mmol/l
6.0
5.9
0.33
416
4013
(3011288) Drugs identified in Urine by Screen method
19
132
1.45
0.77
1.2
2.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
53
1.71
0.75
1.2
1.2
nmol/l
0.9
0.5
—
9
47
(3042631) Mycobacterium sp identified in Specimen
9
56
1.62
0.72
2.3
3.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
36
284
1.29
0.70
1.3
1.4
—
45.9
—
0
14
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
95
0.52
0.67
1.0
1.3
mmol/l
4.8
3.8
—
5
88
(21494755) Public health laboratory ask at order entry panel
37
459
0.79
0.66
1.1
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
28
1.79
0.66
2.4
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
49
1.64
0.62
1.4
1.4
ug/l
25.2
20.8
—
8
49
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
63
1.60
0.62
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
165
1.35
0.61
1.8
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
20
0.00
0.60
0.0
1.3
—
7.0
—
0
20
(3019225) pH of Specimen
51
428
1.21
0.60
6.4
3.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
264
1.27
0.59
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
70
607
1.17
0.58
2.2
2.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
32
257
1.26
0.56
3.9
2.6
u/ml
32.9
49.9
0.49
32
244
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
459
4470
1.13
0.56
4.8
4.3
mmol/l
4.4
4.6
6.42
429
4152
(3007461) Platelets [#/volume] in Blood
521
5119
1.18
0.55
40.4
19.6
e9/l
230.2
250.7
6.25
514
4988
(3014051) Protein [Presence] in Urine by Test strip
13
91
1.44
0.53
3.2
2.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
521
5122
1.18
0.53
40.3
19.6
e12/l
4.4
4.5
6.16
513
4974
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
48
562
0.84
0.52
4.2
4.2
%
29.3
32.4
1.19
37
378
(3000034) Microalbumin [Mass/volume] in Urine
6
40
1.51
0.51
3.2
3.3
mg/l
36.9
18.2
—
6
30
(3010813) Leukocytes [#/volume] in Blood
521
5124
1.17
0.51
40.3
19.7
e9/l
7.0
6.7
1.47
513
4975
(3050129) First trimester maternal screen panel - Serum or Plasma
12
168
0.71
0.51
1.8
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
47
1.50
0.47
1.1
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
439
4280
1.11
0.47
4.4
3.8
mmol/l
1.3
1.3
1.05
404
3940
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
255
1.23
0.46
1.1
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
454
4439
1.11
0.44
4.6
4.2
mmol/l
1.4
1.5
7.40
422
4099
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
31
1.62
0.43
1.4
1.3
—
60.0
—
0
6
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
5
32
1.57
0.42
1.2
1.5
—
21.0
—
0
5
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
401
0.84
0.42
1.9
1.6
—
—
—
0
0
(44813793)
5
33
1.52
0.41
1.2
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
49.8
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.9
—
1.0
—
0
11
(3016018) Differential panel - Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
187
1.24
0.39
1.1
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
169
1.25
0.39
1.3
1.3
miu/ml
208.3
277.4
—
9
83
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
464
4551
1.10
0.38
5.2
4.7
mmol/l
2.6
2.7
4.33
426
4203
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
69
1.31
0.37
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(4034850)
12
157
0.76
0.36
15.7
9.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
117
1.29
0.35
1.2
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
190
1.22
0.35
1.1
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
190
1.22
0.35
1.1
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
55
491
1.13
0.35
2.0
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
182
1.22
0.33
2.7
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
192
1.21
0.32
1.1
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
153
0.78
0.31
1.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
129
1.25
0.30
1.4
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
157
1.22
0.30
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
57
520
1.11
0.27
2.1
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
300
1.14
0.27
2.8
3.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
95
1.27
0.26
1.9
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
86
1.28
0.26
1.0
1.1
u/ml
0.1
2.8
—
6
35
(3017446) Testosterone [Moles/volume] in Serum or Plasma
32
282
1.14
0.26
1.6
2.2
nmol/l
11.0
13.0
0.76
26
258
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
784
1.08
0.25
1.7
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
148
0.81
0.24
1.9
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
243
0.86
0.23
1.5
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
2.2
—
1.2
—
0
10
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
103
0.77
0.21
1.0
1.4
mg/l
645.8
416.7
—
8
98
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
60
558
1.08
0.20
2.2
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
52
1.16
0.19
3.8
4.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
52
484
1.08
0.18
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
60
1.17
0.18
1.1
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
133
1281
1.05
0.17
4.6
4.8
ug/l
2.2
2.6
0.52
120
1145
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
167
1.14
0.17
1.7
1.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
67
0.74
0.17
1.6
1.6
u/l
9.3
25.0
—
5
58
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
69
1.16
0.16
2.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
70
1.14
0.16
2.6
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
70
1.14
0.16
2.6
2.8
mmol/l
104.5
105.6
—
8
70
(3041354) Potassium [Moles/volume] in Venous blood
8
70
1.14
0.16
2.6
2.8
mmol/l
4.0
4.1
—
8
70
(3003740) Influenza virus B Ag [Presence] in Specimen
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
178
1.13
0.15
1.1
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
93
1.19
0.14
1.2
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
70
735
0.95
0.14
3.0
2.9
ug/l
0.7
0.8
0.81
49
470
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
284
0.91
0.13
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
138
0.87
0.13
1.8
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
138
0.87
0.13
1.8
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
138
0.87
0.13
1.8
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
138
0.87
0.13
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
23
252
0.91
0.13
1.7
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
158
1619
0.97
0.12
3.2
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
115
0.87
0.10
2.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
115
0.87
0.10
2.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
22
203
1.09
0.09
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
46
1.09
0.09
1.2
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
87
1.15
0.09
1.2
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
124
0.88
0.09
1.1
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
71
0.84
0.07
2.0
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
70
0.86
0.07
2.2
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
75
1.07
0.07
1.5
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
126
1285
0.98
0.07
1.7
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
85
0.82
0.07
1.0
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
533
0.97
0.04
10.5
6.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
118
0.93
0.03
1.9
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
153
1.05
0.01
1.1
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
101
1017
0.99
0.01
3.9
4.3
%
23.1
22.5
0.14
46
476
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
106
0.94
0.01
2.0
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
196
0.97
0.00
1.2
1.1
—
—
—
0
0
(4094501)
11
108
1.02
0.00
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
112
0.98
0.00
1.1
1.8
nmol/l
44.2
40.2
0.30
11
107
(3002523) Influenza virus A Ag [Presence] in Specimen
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
4.4
—
0.6
—
0
5
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
3693.6
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
66
0.91
0.00
1.3
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
53
0.94
0.00
1.4
1.6
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.1
—
0
8
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.4
—
0
5
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_HAEMORRHAGICNAS and mortality.

Females

Parameter HR [95% CI] p-value
D3_HAEMORRHAGICNAS 2.577 [2.13, 3.11] < 0.001
Birth year 0.996 [0.99, 1.0] 0.377

During the follow-up period (1.1.1998 — 31.12.2019), 542 out of 1833 females with D3_HAEMORRHAGICNAS died.

Males

Parameter HR [95% CI] p-value
D3_HAEMORRHAGICNAS 2.773 [2.18, 3.53] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 549 out of 1402 males with D3_HAEMORRHAGICNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_HAEMORRHAGICNAS.

N-year risk Females Males
1 0.304% 0.488%
5 1.55% 3.02%
10 3.838% 7.322%
15 6.969% 14.394%
20 12.299% 23.449%

Relationships between endpoints

↥

Index endpoint: D3_HAEMORRHAGICNAS – Other and unspecified haemorrhagic conditions

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data